Skip to main content

News

By Jessica Hagen | 12:02 pm | February 12, 2026
The doctor quality analytics company's total funding to date is around $200 million.
By Jessica Hagen | 10:20 am | February 11, 2026
New York-based Somethings will use the funds to scale its mobile app that connects teens and young adults with trained peer mentors.
By Jessica Hagen | 08:00 am | February 11, 2026
The partnership will allow Mira's hormone test results to be compared with Oura Ring data on sleep, temperature and readiness, enabling trend tracking.
By Adam Ang | 07:35 pm | February 10, 2026
A community trial has shown that the data-driven, fall-detecting wearable robot developed at Nanyang Technological University requires less physiotherapist assistance.
By Adam Ang | 07:30 pm | February 10, 2026
Powered by conversational AI, the tool aims to plug Hong Kong's palliative care workforce gap – with fewer than one specialist per 100,000 people – as advance medical directive legislation takes effect in May 2026.
By Jessica Hagen | 01:44 pm | February 10, 2026
The California-based company will use the funds to expand its healthcare advocate network and platform, partnerships with payers and providers and for clinical research.
Emerging Technologies
By Jessica Hagen | 12:21 pm | February 10, 2026
Debra Beauregard, director of medical intelligence and innovation at San Diego-based Rady Children's Health, joins MobiHealthNews to discuss partnering with digital health companies.
By Jessica Hagen | 04:33 pm | February 09, 2026
The company will use the funds to advance its brain shuttle platform that delivers RNAi therapies across the blood-brain barrier to help treat neurodegenerative diseases.
By Jessica Hagen | 01:40 pm | February 09, 2026
The pharma giant alleges that Hims & Hers is infringing its patents and misleading consumers by selling unsafe, unapproved compounded versions of its semaglutide drugs.
By Adam Ang | 07:01 pm | February 08, 2026
Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.